Search research articles
Contact Us
Filters
Showing results (71-80 of 150) with videos related to
Page
of 15
Sort By:
Clinical and Translational Medicine
|
November 16, 2024
Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas
Sameer Mir, Abhilash Venugopalan, Jingli Zhang, et al.
Science Advances
|
May 2, 2025
Robust differentiation of NK cells from MSLN.CAR-IL-15-engineered human iPSCs with enhanced antitumor efficacy against solid tumors
Qun Jiang, Weiming Yu, James Ma, et al.
Cancer Immunology, Immunotherapy : CII
|
January 22, 2010
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin
Robert Sarnovsky, Tara Tendler, Matheusz Makowski, et al.
Plos One
|
February 10, 2011
The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy
Xinran Xiang, Yen Phung, Mingqian Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers
Raffit Hassan, Steven J Cohen, Martin Phillips, et al.
Clinical Genitourinary Cancer
|
June 14, 2017
Clinical Features and Outcomes of Tunica Vaginalis Mesothelioma: A Case Series From the National Institutes of Health
Julie Y An, David Kim, Sally Tanakchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA
Masanori Onda, Mark Willingham, Satoshi Nagata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2011
Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts
Miriam E Mossoba, Masanori Onda, Justin Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice
YuJian Zhang, Laiman Xiang, Raffit Hassan, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 20, 2016
Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy
Peter B Illei, Christine Alewine, Marianna Zahurak, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 150) with videos related to
Sort By:
Page
of 15
Clinical and Translational Medicine
|
November 16, 2024
Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas
Sameer Mir, Abhilash Venugopalan, Jingli Zhang, et al.
Science Advances
|
May 2, 2025
Robust differentiation of NK cells from MSLN.CAR-IL-15-engineered human iPSCs with enhanced antitumor efficacy against solid tumors
Qun Jiang, Weiming Yu, James Ma, et al.
Cancer Immunology, Immunotherapy : CII
|
January 22, 2010
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin
Robert Sarnovsky, Tara Tendler, Matheusz Makowski, et al.
Plos One
|
February 10, 2011
The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy
Xinran Xiang, Yen Phung, Mingqian Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers
Raffit Hassan, Steven J Cohen, Martin Phillips, et al.
Clinical Genitourinary Cancer
|
June 14, 2017
Clinical Features and Outcomes of Tunica Vaginalis Mesothelioma: A Case Series From the National Institutes of Health
Julie Y An, David Kim, Sally Tanakchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA
Masanori Onda, Mark Willingham, Satoshi Nagata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2011
Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts
Miriam E Mossoba, Masanori Onda, Justin Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice
YuJian Zhang, Laiman Xiang, Raffit Hassan, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 20, 2016
Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy
Peter B Illei, Christine Alewine, Marianna Zahurak, et al.
Page
of 15